AI Summary
Thinking
Thinking
We reviewed 3 live results for vaxchora and narrowed them down to the 3 options that look most worth comparing first.
The options are VAXCHORA, VAXCHORA and VAXCHORA.
Source: Unknown source
Description
VAXCHORA is an FDA-approved live, oral cholera vaccine manufactured by Bavarian Nordic A/S. It is indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in individuals 2 through 64 years of age traveling to cholera-affected areas.
Best for
Persons 2 through 64 years of age traveling to cholera-affected areas and Active immunization against disease caused by Vibrio cholerae serogroup O1
Rate this product
Source: Vaxchora
Description
Vaxchora is a single-dose live oral cholera vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in individuals aged 2 through 64 traveling to cholera-affected areas. Reconstituted in healthcare settings and taken at least 10 days before potential exposure, Vaxchora stimulates vibriocidal seroconversion and protects against cholera-induced moderate to severe diarrhea. It is supplied as a single-dose carton containing active and buffer component packets.
Best for
Travelers aged 2 to 64 years visiting cholera-affected areas and Active immunization against Vibrio cholerae serogroup O1 prior to travel
Rate this product
Source: Vaxchora
Description
VAXCHORA is an FDA-approved prescription live oral vaccine indicated to help protect individuals aged 2 through 64 years against cholera caused by Vibrio cholerae serogroup O1 when traveling to areas of active transmission. Administered as a single oral dose prepared in a healthcare provider's office or pharmacy at least 10 days before travel, it was demonstrated in clinical trials to be 90.3% effective at 10 days and 79.5% effective at 3 months post-vaccination.
Best for
Travelers aged 2 to 64 years traveling to areas of active cholera transmission and Immunization against cholera caused by Vibrio cholerae serogroup O1 prior to international travel
Rate this product
| Compare | #1VAXCHORA | #2VAXCHORA | #3VAXCHORA |
|---|---|---|---|
| Source | Unknown source | Vaxchora | Vaxchora |
| Description | VAXCHORA is an FDA-approved live, oral cholera vaccine manufactured by Bavarian Nordic A/S. It is indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in individuals 2 through 64 years of age traveling to cholera-affected areas. | Vaxchora is a single-dose live oral cholera vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in individuals aged 2 through 64 traveling to cholera-affected areas. Reconstituted in healthcare settings and taken at least 10 days before potential exposure, Vaxchora stimulates vibriocidal seroconversion and protects against cholera-induced moderate to severe diarrhea. It is supplied as a single-dose carton containing active and buffer component packets. | VAXCHORA is an FDA-approved prescription live oral vaccine indicated to help protect individuals aged 2 through 64 years against cholera caused by Vibrio cholerae serogroup O1 when traveling to areas of active transmission. Administered as a single oral dose prepared in a healthcare provider's office or pharmacy at least 10 days before travel, it was demonstrated in clinical trials to be 90.3% effective at 10 days and 79.5% effective at 3 months post-vaccination. |
| Best for | Persons 2 through 64 years of age traveling to cholera-affected areas and Active immunization against disease caused by Vibrio cholerae serogroup O1 | Travelers aged 2 to 64 years visiting cholera-affected areas and Active immunization against Vibrio cholerae serogroup O1 prior to travel | Travelers aged 2 to 64 years traveling to areas of active cholera transmission and Immunization against cholera caused by Vibrio cholerae serogroup O1 prior to international travel |
| Action | VAXCHORA | Vaxchora | Vaxchora |
| Rate this product |
"VAXCHORA."
Note: TopFind AI compiles product and service information for general comparison purposes only.